|
1.
|
Cooper JS, Porter K, Mallin K, et al:
National Cancer Database report on cancer of the head and neck:
10-year update. Head Neck. 31:748–758. 2009.PubMed/NCBI
|
|
2.
|
Almadori G, Bussu F, Cadoni G, Galli J,
Paludetti G and Maurizi M: Molecular markers in laryngeal squamous
cell carcinoma: towards an integrated clinicobiological approach.
Eur J Cancer. 41:683–693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Krecicki T, Zalesska-Krecicka M, Jagas M,
Szajowski K and Rak J: Laryngeal cancer in Lower Silesia:
descriptive analysis of 501 cases. Oral Oncol. 34:377–380. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar
|
|
5.
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Des Guetz G, Uzzan P, Nicolas P, et al:
Microvessel density and VEGF expression are prognostic factors in
colorectal cancer. Meta-analysis of the literature. Br J Cancer.
94:1823–1832. 2006.PubMed/NCBI
|
|
8.
|
Beatrice F, Valente R, Cammarota R, et al:
Laryngeal cancer and angiogenesis. Acta Otorhinolaryngol Ital.
16:355–362. 1996.
|
|
9.
|
Korampalli TS, Green VL, Greenman J and
Stafford ND: Protein profiling of angiogenesis-related growth
factors in laryngeal carcinoma: Pattern of protein expression in
relation to tumour progression. Int J Oncol. 39:1033–1039.
2011.
|
|
10.
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar
|
|
11.
|
Chen Z, Malhotra PS, Thomas GR, et al:
Expression of proinflammatory and proangiogenic cytokines in
patients with head and neck cancer. Clin Cancer Res. 5:1369–1379.
1999.PubMed/NCBI
|
|
12.
|
Ruokolainen H, Paakko P and
Turpeenniemi-Hujanen T: Tissue inhibitor of matrix
metalloproteinase-1 is prognostic in head and neck squamous cell
carcinoma: comparison of the circulating and tissue immunoreactive
protein. Clin Cancer Res. 11:3257–3264. 2005. View Article : Google Scholar
|
|
13.
|
Gao X and Xu Z: Mechanisms of action of
angiogenin. Acta Biochim Biophys Sin (Shanghai). 40:619–624. 2008.
View Article : Google Scholar
|
|
14.
|
Katona TM, Neubauer BL, Iversen PW, Zhang
S, Baldeidge LA and Cheng L: Elevated expression of angiogenin in
prostate cancer and its precursors. Clin Cancer Res. 11:8358–8363.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Marioni G, Marioni F, Blandamura S, et al:
Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105
expression is related to carcinoma recurrence rate and disease-free
survival. Histopathology. 57:535–543. 2010. View Article : Google Scholar
|
|
16.
|
Baxter RC: Signalling pathways involved in
antiproliferative effects of IGFBP-3: a review. Mol Pathol.
54:145–148. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Stewart CE and Rotwein P: Growth,
differentiation, and survival: multiple physiological functions for
insulin-like growth factors. Physiol Rev. 76:1005–1026.
1996.PubMed/NCBI
|
|
18.
|
Samani AA, Yakar S, LeRoith D and Brodt P:
The role of the IGF system in cancer growth and metastasis:
overview and recent insights. Endocr Rev. 28:20–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Pollak MN, Schernhammer ES and Hankinson
SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer.
4:505–518. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Ulanet DB, Ludwig DL, Kahn CR and Hanahan
D: Insulin receptor functionally enhances multistage tumour
progression and conveys intrinsic resistance to IGF-1R targeted
therapy. Proc Natl Acad Sci USA. 107:10791–10798. 2010. View Article : Google Scholar
|
|
21.
|
Wu X, Zhao H, Do KA, Johnson MM, Dong Q,
Hong WK and Splitz MR: Serum levels of insulin growth factor
(IGF-I) and IGF-binding protein predict risk of second primary
tumours in patients with head and neck cancer. Clin Cancer Res.
10:3988–3995. 2004. View Article : Google Scholar
|
|
22.
|
Papadimitrakopoulou VA, Brown EN, Liu DD,
El-Naggar AK, Jack Lee J, Hong WK and Lee HY: The prognostic role
of loss of insulin-like growth factor-binding protein-3 expression
in head and neck carcinogenesis. Cancer Lett. 239:136–143. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Shang ZJ, Li ZB and Li JR: VEGF is
up-regulated by hypoxic stimulation and related to tumour
angiogenesis and severity of disease in oral squamous cell
carcinoma: in vitro and in vivo studies. Int J Oral Maxillofac
Surg. 35:533–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Ferrara N: Vascular endothelial growth
factor. Eur J Cancer. 32A:2413–2422. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Tae K, El-Naggar AK, Yoo E, et al:
Expression of vascular endothelial growth factor and microvessel
density in head and neck tumourigenesis. Clin Cancer Res.
6:2821–2828. 2000.PubMed/NCBI
|
|
26.
|
Bandoh N, Hayashi T, Takahara M, et al:
VEGF and bFGF expression and microvessel density of maxillary sinus
squamous cell carcinoma in relation to p53 status, spontaneous
apoptosis and prognosis. Cancer Lett. 208:215–225. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Sullu Y, Gun S, Atmaca S, Karagoz F and
Kandemir B: Poor prognostic clinicopathologic features correlate
with VEGF expression but not with PTEN expression in squamous cell
carcinoma of the larynx. Diagn Pathol. 5:352010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Li W, Wang C, Juhn SK, Ondrey FG and Lin
J: Expression of fibroblast growth factor binding protein in head
and neck cancer. Arch Otolaryngol Head Neck Surg. 135:896–901.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Druzgal CH, Chen Z, Yeh NT, et al: A pilot
study of longitudinal serum cytokine and angiogenesis factor levels
as markers of therapeutic response and survival in patients with
head and neck squamous cell carcinoma. Head Neck. 27:771–784. 2005.
View Article : Google Scholar
|
